NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Midday movers: Costco, Warner Bros. Discovery, Rivian and more

Published 09/27/2023, 07:58 AM
Updated 09/27/2023, 12:58 PM
© Reuters.
WBD
-
ZION
-
AMZN
-
COST
-
MAT
-
MAR
-
MLKN
-
CRDF
-
RIVN
-

Investing.com -- U.S. stocks erased early gains and turned lower, weighed by concerns about higher for longer interest rates and the rising potential for a government shutdown this weekend.

Here are some of the biggest U.S. stock movers today:

  • Costco (NASDAQ:COST) stock rose 1.5% as fourth quarter results beat expectations on both the top and bottom lines.

  • Warner Bros Discovery Inc (NASDAQ:WBD) shares rose 2.2% after Hollywood's writer's union ended its strike against major studios and streaming platforms, with a new tentative three year contract. Shares of Paramount Global Class B (NASDAQ:PARA) rose 1.9%.
  • Rivian (NASDAQ:RIVN) stock fell 0.4% after the EV manufacturer announced plans to use subscription models for monetizing various features in cars.

  • Amazon (NASDAQ:AMZN) stock fell 0.9% after the Federal Trade Commission filing a long-awaited antitrust lawsuit against the online retail giant.

  • Zions Bancorporation (NASDAQ:ZION) stock fell 0.9% after Morgan Stanley downgraded the lender to ‘underweight’ from ‘equal weight’, citing an elevated valuation after gains of over 70% since May lows.

  • Mattel (NASDAQ:MAT) stock rose 3.7% after the toymaker posted a surprise profit in the second quarter and its sales exceeded market expectations, while the box office success of the "Barbie" movie is likely to help drive doll sales in the second half of the year.

  • Marriott International (NASDAQ:MAR) stock rose 0.7% after the hotel operator forecast two-year annualized global revenue per available room growth of 3% to 6% by 2025, expecting resilient international travel demand.

  • MillerKnoll (NASDAQ:MLKN) stock rose 28.7% after the upmarket furniture-maker raised its full-year profit outlook.

  • Cardiff Oncology (NASDAQ:CRDF) stock rose 4.3% after the biotechnology company announced favorable data from two cancer drug trials.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.